secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moderna, Inc. (MRNA)
CIK:        0001682852
Form:       8-K
Filed at:   2024-07-23T23:59:59+00:00
Accession:  0001682852-24-000035
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moderna appoints David Rubenstein to board; co-founders Langer and Berenson retire
--------------------------------------------------------------------------------

- David Rubenstein (Carlyle Co-Founder) joins Moderna board effective Aug 5, 2024, replacing Stephen Berenson on Audit Committee.
- Robert Langer and Stephen Berenson will retire from board on Aug 5, 2024; both will provide advisory services through Nov 1, 2026.
- Dr. Langer's and Mr. Berenson's resignations not due to any disagreement with Moderna's operations or policies.
- Board size fixed at eight directors; search ongoing for replacement with scientific/innovation experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682852/000168285224000035/0001682852-24-000035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682852/000168285224000035/mrna-20240719.htm
  HTML page:      https://secwatch.observer/filing/0001682852-24-000035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer